Technetium Tc 99m Sestamibi
"Technetium Tc 99m Sestamibi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
| Descriptor ID |
D017256
|
| MeSH Number(s) |
D02.626.872 D02.691.825.937
|
| Concept/Terms |
Technetium Tc 99m Sestamibi- Technetium Tc 99m Sestamibi
- Tc-99m-Methoxy-2-isobutylisonitrile
- Tc 99m Methoxy 2 isobutylisonitrile
- Technetium-99m-Hexamibi
- Technetium 99m Hexamibi
- Tc MIBI
- 99mTc-Hexamibi
- 99mTc Hexamibi
- 99mTc-Sestamibi
- 99mTc Sestamibi
- Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile
- Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
- Technetium-99m-Sestamibi
- Technetium 99m Sestamibi
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Sestamibi".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Sestamibi".
This graph shows the total number of publications written about "Technetium Tc 99m Sestamibi" by people in this website by year, and whether "Technetium Tc 99m Sestamibi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Sestamibi" by people in Profiles.
-
Surgical challenges of giant parathyroid adenomas weighing 10?g or more. J Endocrinol Invest. 2023 Jun; 46(6):1169-1176.
-
American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019 07; 41(7):2398-2409.
-
Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Ann Surg Oncol. 2016 12; 23(Suppl 5):701-707.
-
Adenoma localization for recurrent or persistent primary hyperparathyroidism using dynamic four-dimensional CT and venous sampling. J Vasc Interv Radiol. 2015 Jan; 26(1):79-86.
-
A novel technique to improve the?diagnostic yield of negative sestamibi scans. Surgery. 2014 Sep; 156(3):584-90.
-
Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011 Jun; 18(6):1717-22.
-
Benefits of surgeon-performed ultrasound for primary hyperparathyroidism. Langenbecks Arch Surg. 2009 Sep; 394(5):861-7.
-
Sestamibi scanning and outcomes in minimally invasive parathyroidectomy. Endocr Pract. 2006 Nov-Dec; 12(6):615-21.
-
What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery. 2006 Sep; 140(3):418-22.
-
An algorithm to maximize use of minimally invasive parathyroidectomy. Arch Surg. 2004 May; 139(5):501-6; discussion 506-7.